Integrated BioPharma

(OTC) INBP

Current Price$0.18

Market Cap$5.61M

Since IPO (1995)-97%

5 Year-85%

1 Year-42%

1 Month-28%

Integrated BioPharma Financials at a Glance

Market Cap

$5.61M

Revenue (TTM)

$48.25M

Net Income (TTM)

-$1.65M

EPS (TTM)

-$0.05

P/E Ratio

-3.38

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Price

$0.18

Volume

Open

$0.20

Price

$0.18

Volume

Open

$0.20

Previous Close

$0.18

Daily Range

$0.17 - $0.20

52-Week Range

$0.17 - $0.42

Estimated Earnings Date

May 8, 2026

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Price

$0.18

Volume

Open

$0.20

Previous Close

$0.18

Daily Range

$0.17 - $0.20

52-Week Range

$0.17 - $0.42

Estimated Earnings Date

May 8, 2026

INBP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Integrated BioPharma

Industry

Personal Products

Sector

Consumer Staples

Employees

153

CEO

Christina Kay; Riva Kay Sheppard

Website

ir.ibiopharma.com

Headquarters

Hillside, NJ 07205, US

INBP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

-8%

Return on Capital

-6%

Return on Assets

-6%

Earnings Yield

-29.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.61M

Shares Outstanding

31.06M

Volume

Avg. Volume

7.63K

Financials (TTM)

Gross Profit

$5.56M

Operating Income

$2.02M

EBITDA

$3.38M

Operating Cash Flow

$2.07M

Capital Expenditure

-$191.00K

Free Cash Flow

$1.87M

Cash & ST Invst.

$3.62M

Total Debt

$1.02M

Integrated BioPharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$10.11M

-27.5%

Gross Profit

-$276.00K

-117.8%

Gross Margin

-2.73%

N/A

Market Cap

$5.61M

N/A

Market Cap/Employee

$38.19K

N/A

Employees

147

N/A

Net Income

-$837.00K

-237.0%

EBITDA

-$729.00K

-169.9%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

$5.83M

+96.8%

Total Debt

$3.35M

+194.5%

Accounts Receivable

$3.66M

-28.1%

Inventory

$8.12M

-19.4%

Long Term Debt

$2.16M

+639.7%

Short Term Debt

$1.19M

+40.5%

Return on Assets

-6.20%

N/A

Return on Invested Capital

-5.90%

N/A

Free Cash Flow

$517.00K

+3.4%

Operating Cash Flow

$517.00K

-16.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NGTFNightfood Holdings, Inc.

NGTFNightfood Holdings, Inc.$0.03+15.38%

BABBBAB, Inc.

BABBBAB, Inc.$0.90+1.12%

HIGRHi-Great Group Holding Company

HIGRHi-Great Group Holding Company$0.03+0.00%

EWLUMerion, Inc.

EWLUMerion, Inc.$0.00+0.00%

HNFSAHanover Foods Corporation

HNFSAHanover Foods Corporation$50.00+0.00%

IRCKFInter-Rock Minerals Inc.

IRCKFInter-Rock Minerals Inc.$0.74+0.00%

NPRFFNepra Foods Inc.

NPRFFNepra Foods Inc.$0.16-6.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About INBP

What is the current price of Integrated BioPharma?

Integrated BioPharma is trading at $0.18 per share.

What is the 52-week range for Integrated BioPharma?

Over the past 52 weeks, Integrated BioPharma has traded between $0.17 and $0.42.

How much debt does Integrated BioPharma have?

As of the most recent reporting period, Integrated BioPharma reported total debt of $3.35M.

How much cash does Integrated BioPharma have on hand?

Integrated BioPharma reported $5.83M in cash and cash equivalents in its most recent financial results.

What is Integrated BioPharma’s dividend yield?

Integrated BioPharma does not currently have a dividend yield.

Integrated BioPharma

Integrated BioPharma Financials at a Glance

INBP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Integrated BioPharma

INBP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Integrated BioPharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INBP

What is the current price of Integrated BioPharma?

What is the 52-week range for Integrated BioPharma?

How much debt does Integrated BioPharma have?

How much cash does Integrated BioPharma have on hand?

What is Integrated BioPharma’s dividend yield?

Premium Investing Services